Ameloblastic fibrosarcoma – A rarity?

Ameloblastic fibrosarcoma (AFS) is a rare malignant odontogenic tumour classified by the WHO (1992) as an odontogenic sarcoma and defined as “a neoplasm with a similar structure to ameloblastic fibroma (AF) but in which the ectomesenchymal component shows the features of a sarcoma.” The first report...

Descripción completa

Detalles Bibliográficos
Autores principales: M.S. Munisekhar, Sanjeevareddigari Shylaja, R. Vijay Kumar, Krishna A. Rao, Santosh R. Patil, Mohammad Khursheed Alam
Formato: Artículo
Lenguaje:English
Publicado: Elsevier 2019-09-01
Colección:JPRAS Open
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2352587819300221
Descripción
Sumario:Ameloblastic fibrosarcoma (AFS) is a rare malignant odontogenic tumour classified by the WHO (1992) as an odontogenic sarcoma and defined as “a neoplasm with a similar structure to ameloblastic fibroma (AF) but in which the ectomesenchymal component shows the features of a sarcoma.” The first report of AFS was published by Heath in 1887. AFS and related lesions are less frequently diagnosed than odontogenic carcinomas. Approximately two-thirds of AFSs seem to arise de novo, but others have developed in recurrent AF, in which the ectomesenchymal cells retain their embryonic appearance and develop malignant characteristics. We report a rare case of an aggressive odontogenic neoplasm, the incisional biopsy of which showed the features of AF, while the excisional biopsy revealed the features of malignancy, suggestive of AFS.The purpose of this report is to discuss the diagnostic difficulties, whether AFS is truly an extremely rare tumour as reported earlier and, lastly, should the treatment protocols of AFs be revised, as 44% of AFSs arise from recurrent AFs. Keywords: Odontogenic fibrosarcoma, Odontogenic sarcoma, Ameloblastic fibrosarcoma, Ameloblastic fibroma
ISSN:2352-5878